Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Lipid Res ; 54(5): 1312-25, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23410936

RESUMEN

Barth syndrome is a complex metabolic disorder caused by mutations in the mitochondrial transacylase tafazzin. Recently, an inducible tafazzin shRNA knockdown mouse model was generated to deconvolute the complex bioenergetic phenotype of this disease. To investigate the underlying cause of hemodynamic dysfunction in Barth syndrome, we interrogated the cardiac structural and signaling lipidome of this mouse model as well as its myocardial bioenergetic phenotype. A decrease in the distribution of cardiolipin molecular species and robust increases in monolysocardiolipin and dilysocardiolipin were demonstrated. Additionally, the contents of choline and ethanolamine glycerophospholipid molecular species containing precursors for lipid signaling at the sn-2 position were altered. Lipidomic analyses revealed specific dysregulation of HETEs and prostanoids, as well as oxidized linoleic and docosahexaenoic metabolites. Bioenergetic interrogation uncovered differential substrate utilization as well as decreases in Complex III and V activities. Transgenic expression of cardiolipin synthase or iPLA2γ ablation in tafazzin-deficient mice did not rescue the observed phenotype. These results underscore the complex nature of alterations in cardiolipin metabolism mediated by tafazzin loss of function. Collectively, we identified specific lipidomic, bioenergetic, and signaling alterations in a murine model that parallel those of Barth syndrome thereby providing novel insights into the pathophysiology of this debilitating disease.


Asunto(s)
Síndrome de Barth/metabolismo , Cardiolipinas/metabolismo , Metabolismo de los Lípidos , Lípidos/biosíntesis , Mitocondrias Cardíacas/metabolismo , Animales , Animales Modificados Genéticamente , Síndrome de Barth/patología , Cardiolipinas/genética , Modelos Animales de Enfermedad , Metabolismo Energético , Regulación de la Expresión Génica , Humanos , Lípidos/genética , Masculino , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Ratones , Mitocondrias Cardíacas/patología , Membranas Mitocondriales/metabolismo , Transducción de Señal , Transferasas (Grupos de Otros Fosfatos Sustitutos)/genética , Transferasas (Grupos de Otros Fosfatos Sustitutos)/metabolismo
2.
Anal Biochem ; 425(2): 104-12, 2012 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-22446499

RESUMEN

The separation and detection of individual amyloid beta (Aß) aggregates by capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) was demonstrated. Samples were prepared with either Aß (1-40) or Aß (1-42) peptides and were characterized by CE with ultraviolet (UV) absorbance detection and transmission electron microscopy (TEM). Using thioflavin T (ThT) in the electrophoresis buffer, electrophoresis of aggregate-containing samples (5.0-s injection) produced up to several hundred narrow (< 20 ms FWHM [full width at half maximum]) fluorescence peaks. Injection of Aß (1-40) monomer samples resulted in no additional peaks compared with controls. The CE-LIF results were validated by bulk ThT fluorescence measurements for the same samples. The potential of laser-induced fluorescence anisotropy (LIFA) with CE to characterize individual Aß aggregates also was investigated.


Asunto(s)
Péptidos beta-Amiloides/análisis , Electroforesis Capilar , Rayos Láser , Fragmentos de Péptidos/análisis , Espectrofotometría Ultravioleta , Péptidos beta-Amiloides/aislamiento & purificación , Benzotiazoles , Microscopía Electrónica de Transmisión de Rastreo , Fragmentos de Péptidos/aislamiento & purificación , Tiazoles/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA